The Scientist

» biotechnology and ecology

Most Recent

image: Characterizing DNA Quadruplexes

Characterizing DNA Quadruplexes

By | September 10, 2015

Researchers are developing new techniques to better understand how and why knots of DNA are distributed throughout the genome.

0 Comments

image: Citation Payola?

Citation Payola?

By | August 18, 2015

A transgenic mouse company is paying researchers who mention its animal models in scientific papers.

1 Comment

image: Butterflies in Peril

Butterflies in Peril

By | August 12, 2015

Several recent studies point to serious—and mysterious—declines in butterfly numbers across the globe.

5 Comments

image: FDA Approves 3-D–Printed Drug

FDA Approves 3-D–Printed Drug

By | August 4, 2015

The US Food and Drug Administration green lights the first medicine produced by a 3-D printer for use in the human body.

1 Comment

image: Mimicry Muses

Mimicry Muses

By | August 1, 2015

The animal world is full of clever solutions to bioengineering challenges.

0 Comments

image: RoboSpleen

RoboSpleen

By | August 1, 2015

Witness a bioinspired device developed by researchers at Harvard’s Wyss Institute to treat sepsis.

1 Comment

image: Inspired by Nature

Inspired by Nature

By | August 1, 2015

Researchers are borrowing designs from the natural world to advance biomedicine.

0 Comments

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

image: FDA OKs Herpes Blood Test

FDA OKs Herpes Blood Test

By | July 6, 2015

The US Food and Drug Administration approves Theranos’s fingerstick test for herpes.

0 Comments

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS